The effect of sodium-n-dipropyl acetate on gamma-aminobutyric acid-dependent inhibition in the rat cortex and substantia nigra in relation to its anticonvulsant activity
- PMID: 6781578
- PMCID: PMC2044476
- DOI: 10.1111/j.1476-5381.1980.tb10971.x
The effect of sodium-n-dipropyl acetate on gamma-aminobutyric acid-dependent inhibition in the rat cortex and substantia nigra in relation to its anticonvulsant activity
Abstract
1. We have examined the time course of the anticonvulsant property of valproate sodium on electroshock-induced convulsions in rats and a comparison of this has been made with the action of the drug on single unit activity in the rat brain. 2. Intraperitoneal valproate sodium (100 to 400 mg/kg) protected rats from electroshock-induced convulsion. This effect was dose-dependent, the latency of the effect decreasing as a function of dose from 5 to 2 min. 3. The time course of this anticonvulsant property was paralleled by a pronounced inhibition of the spontaneous firing rate of cortical and nigral neurones, following intraperitoneal administration of valproate sodium (100 to 400 mg/kg). 4. The inhibitory action of microiontophoretically applied gamma-aminobutyric acid (GABA) and muscimol on the firing rate of cortical neurones was potentiated within 1 to 3 min of microiontophoretic application of valproate sodium. In contrast, the inhibitory action of glycine on cortical neurones was unaffected during the microiontophoretic application of valproate sodium. 5. Microiontophoretically applied valproate sodium also potentiated inhibitory responses to GABA in rats which had received 100 mg/kg of a GABA-transaminase inhibitor, gabaculine, i.p. 16 h previously. 6. The duration of trans-synaptic inhibitory responses in the substantia nigra and cortex following submaximal electrical stimulation of the striatum and cortex respectively was, in general, unaffected by either intraperitoneal or local application of valproate sodium. 7. These observations are discussed in terms of the mechanisms underlying the rapid onset of the anticonvulsant properties of valproate sodium.
Similar articles
-
Sodium valproate enhancement of gamma-aminobutyric acid (GABA) inhibition: electrophysiological evidence for anticonvulsant activity.J Pharmacol Exp Ther. 1981 May;217(2):445-50. J Pharmacol Exp Ther. 1981. PMID: 6785416
-
Valproate enhances GABA turnover in the substantia nigra.Brain Res. 1989 Oct 30;501(1):198-203. doi: 10.1016/0006-8993(89)91044-5. Brain Res. 1989. PMID: 2508993
-
Neuronal activity, amino acid concentration and amino acid release in the substantia nigra of the rat after sodium valproate.Brain Res. 1989 Dec 11;504(1):49-56. doi: 10.1016/0006-8993(89)91596-5. Brain Res. 1989. PMID: 2513086
-
Valproate and myoclonus.Adv Neurol. 1986;43:661-74. Adv Neurol. 1986. PMID: 3080855 Review.
-
Cellular compartments of GABA in brain and their relationship to anticonvulsant activity.Mol Cell Biochem. 1981 Sep 25;39:305-29. doi: 10.1007/BF00232582. Mol Cell Biochem. 1981. PMID: 6273710 Review. No abstract available.
Cited by
-
Valproate enhances GABA-A mediated inhibition of locus coeruleus neurones in vitro.Naunyn Schmiedebergs Arch Pharmacol. 1988 Dec;338(6):655-7. doi: 10.1007/BF00165630. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 2854215
-
The role of the brain stem in generalized epileptic seizures.Metab Brain Dis. 1987 Jun;2(2):81-112. doi: 10.1007/BF00999720. Metab Brain Dis. 1987. PMID: 3333172 Review. No abstract available.
-
Suppression of preoptic GABA release caused by push-pull-perfusion with sodium valproate.Naunyn Schmiedebergs Arch Pharmacol. 1988 Dec;338(6):658-63. doi: 10.1007/BF00165631. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 3149723
-
Invertebrate neurons as a simple model to study the hyperexcitable state of epileptic disorders in single cells, monosynaptic connections, and polysynaptic circuits.Biophys Rev. 2022 Mar 30;14(2):553-568. doi: 10.1007/s12551-022-00942-w. eCollection 2022 Apr. Biophys Rev. 2022. PMID: 35528035 Free PMC article. Review.
-
Drugs that increase gamma-aminobutyric acid transmission protect against the high pressure neurological syndrome.Br J Pharmacol. 1982 Jul;76(3):447-52. doi: 10.1111/j.1476-5381.1982.tb09238.x. Br J Pharmacol. 1982. PMID: 6286024 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources